Abstract The conserved Lipoprotein-17 domain of membrane-associated protein Q9PRA0_UREPA from Ureaplasma parvum was selected for structure determination by the Northeast Structural Genomics Consortium, as part of the Protein Structure Initiative's program on structure-function analysis of protein domains from large domain sequence families lacking structural representatives. The 100-residue Lipoprotein-17 domain is a ''domain of unknown function'' (DUF) that is a member of Pfam protein family PF04200, a large domain family for which no members have characterized biochemical functions. The three-dimensional structure of the Lipoprotein-17 domain of protein Q9PRA0_UREPA was determined by both solution NMR and by X-ray crystallography at 2.5 Å . The two structures are in good agreement with each other. The domain structure features three a-helices, a1 through a3, and five b-strands. Strands b1/b2, b3/b4, b4/b5 are antiparallel to each other. Strands b1and b2 are orthogonal to strands b3, b4, b5, while helix a3 is formed between the strands b3 and b4. One-turn helix a2 is formed between the strands b1 and b2, while helix a1 occurs in the N-terminal polypeptide segment. Searches of the Protein Data Bank do not identify any other protein with significant structural similarity to Lipoprotein-17 domain of Q9PRA0_UREPA, indicating that it is a novel protein fold.
Introduction
The 100-residue domain of the conserved membrane-associated lipoprotein from Ureaplasma parvum (NESG ID: UuR17A, Swiss Prot ID: Q9PRA0_UREPA) was selected for three-dimensional (3D) structure determination by the Northeast Structural Genomics Consortium (NESG; http://www.nesg.org) as part of the NIH Protein Structure Initiative program on structural coverage of large domain families. Q9PRA0_UREPA [10] is a conserved putative lipoprotein from U. parvum. It contains 834 amino acid residues and has a polypeptide chain molecular mass of 95.9 kDa. Amino acid sequence analysis suggests the presence of at least two conserved domains with unknown functions: Lipoprotein-17 (lipoprotein associated domain, pfam04200) and DUF31 (pfam01732) (Pfam protein family [4] ). Lipoprotein-17 domain of Q9PRA0_UREPA is a member of the pfam04200 domain family (http://pfam. sanger.ac.uk/family?acc=PF04200). It is approximately 100 residues in length (residues 139-239) and has been found exclusively in six Mycoplasma and Ureaplasma species, both of which belong to Mycoplasmataceae family [4] . Some Mycoplasma proteins contain 3-7 repeats of the Lipoprotein-17 domain [4] . The pfam04200 domain family has more than 113 known members, none of which have significant sequence similarity with any protein of known 3D structure [4] . Here we report the high-quality NMR solution structure (construct spanning residues 128-239) and 2.5-Å resolution X-ray structure (construct spanning residues 133-249) of the Lipoprotein-17 domain of Q9PRA0_UREPA, the first member of the pfam04200 domain family for which a 3D structure has been reported.
Materials and methods

Protein sample preparation
The gene fragment coding for the Lipoprotein-17 domain of the Q9PRA0_UREPA protein from U. parvum (UniProtKB/ Swiss-Prot ID Q9PRA0_UREPA) was cloned into an E. coli expression plasmid. The corresponding protein was expressed and purified following standard, largelyautomated protocols of the NESG consortium, to produce protein samples for structure determination by both NMR and X-ray crystallography [1] . For NMR studies, a truncated UU045 gene construct (residues 128-239) was cloned into a pET21 (Novagen) expression vector derivative (pET21_NESG, Ref. [1] Fig. S1 ) and 15 N T 1 and T 2 relaxation data ( Supplementary Fig. S2 ) indicate that these protein constructs are monomeric in solution under the conditions used for NMR studies.
Protein NMR studies
Protein samples for NMR studies were prepared at concentrations of *1.0 mM in 95% H 2 O/5% 2 H 2 O buffer Supplementary  Fig. S3 . NMR data supporting the resonance assignments are summarized in Supplementary Fig. S4 . Resonance assignments were deposited in the BioMagResBank on 12/22/2009 with accession code 16648. The locations of regular secondary structure elements were next identified based on backbone chemical shift data [24] . A NOESY peak list containing expected intra-residue, sequential, and a-helical medium-range NOE peaks was initially generated and then manually edited by visual inspection of NOESY spectra [19] . The programs CYANA [11, 12] and AutoStructure [3, 15] were used in parallel to automatically assign long-range NOEs. Statistical summaries of 1 H-1 H upper-bound distance constraints used for structure calculations are summarized in Table 1 . Backbone dihedral angle constraints were derived from chemical shift data using the program TALOS? [22] (Table 1 ). The final structure calculation was performed with AutoStructure 2.0, and the 20 conformers with the lowest target function value were refined in an 'explicit water bath' [18] using the program CNS [6] . Coordinates were deposited in the Protein Data Bank on 12/22/2009 (PDB accession code 2KRT).
Protein crystallization and crystallography
Crystallization screening was performed using a microbatch-under-oil crystallization method at 18°C [7] , followed by crystallization optimization. Crystals of selenomethionine-derivatized Lipoprotein-17 domain of Q9PRA0_UREPA protein used for structure determination were grown in drops composed of 0.5 uL of protein and 0.5 ll of precipitant solution (100 mM HEPES, pH 7.5, 100 mM potassium bromide, 40% (w/v) PEG8000) under mineral oil (Hampton Research). The crystals were transferred to paratone oil to remove excess mother liquor before being frozen in liquid propane for data collection at 100 K. Single-wavelength anomalous dispersion (SAD) data were collected at the peak wavelength of the selenium K edge using beamline X4A at the National Synchrotron Light Source. These diffraction data were processed with the HKL2000 package [20] . The crystal belongs to space group P3 2 21 , with cell parameters of a = b=60.56 Å , c = 64.72 Å . The program SHELXE/D [21] was used to locate a selenium site and to calculate phases to 2.8 Å resolution. Solvent-flattening calculations and partial model building were performed using RESOLVE [23] . The model was completed manually using Coot [9] , and was refined against 2.49 Å data with the program PHENIX [2] . The quality of the model was inspected by the program PROCHECK [17] . There is one molecule of the Lipoprotein-17 domain of Q9PRA0_UREPA in the crystallographic asymmetric unit. Data collection and refinement statistics are shown in Table 2 . The atomic coordinates and experimental structure factors have been deposited in the Protein Data Bank on 10/08/2009 (PDB accession code 3K63). 
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Results and discussion
The solution NMR structure of the Lipoprotein-17 domain of Q9PRA0_UREPA (residues 128-239, PDB ID 2KRT) is shown in Fig. 1 . Structure quality statistics for this NMR structure are presented in Table 1 (a more complete set of structure quality statistics are presented in Supplementary  Table S1 ). This solution NMR structure exhibits excellent quality assessment scores. The domain structure comprises three a-helices, a1, a2, and a3, and five b-strands (Fig. 1) . Strands b1-b2, b3-b4, and b4-b5 are anti-parallel to each other (Fig 1) . Strands b1-b2 lie orthogonal to the b-sheet formed by strands b3, b4, and b5, while helix a3 is formed between strands b3 and b4. A single-turn helix a2 is formed between strands b1 and b2, while helix a1 is formed by the N-terminal polypeptide segment. The protein core, consisting of residues 128-239, is well ordered, while the C-terminal segment, including the hexaHis purification tag, is flexible in solution. The 2.5-Å X-ray crystal structure of the Lipoprotein-17 domain of Q9PRA0_UREPA (residues 133-249, PDB ID 3K63) is shown in Fig. 2a , and the corresponding refinement statistics are presented in Table 2 . The X-ray and NMR structures are superimposed in Fig. 2b . The two structures are generally in good agreement with each other. All five b-strand structures are similar in the NMR and X-ray structures. Differences between the NMR and X-ray structures are observed in flexible loop regions, the disordered C-terminal segment (which is longer in the construct used for crystallographic studies), and in the orientation of N-terminal helix a1. The X-ray structure shows two singleturn helices (residues 160-162 and 172-174) which are not observed in the NMR structure. This difference may be due to the weak intensity of these resonances in the NMR spectra, presumably due to exchange broadening resulting from internal motions. While such dynamics are sometimes functionally important, we cannot speculate on their functional relevance in Lipoprotein-17, as the protein's function is currently unknown. The difference in relative orientation of helix a1 in the NMR and X-ray structures (Fig. 2b ) may be due to flexibility that is commonly seen in such N-terminal polypeptide segments. [16] and PYMOL [8] A Dali [13] search for structurally-similar proteins did not produce any significant hits with other protein structures in the Protein Data Bank. The highest Dali Z-scores are at about the threshold of being significant (about 4.0). A comparison of the structure of Lipoprotein-17 domain of Q9PRA0_UREPA with a putative tail lysozyme from Geobacter sulfurreducens (PDB ID 2IA7, Fig 2d) which has the highest Dali Z-score = 4 and sequence identity of only 7% (using a structure-based sequence alignment), does not reveal much structural similarity. The overall structure of 2IA7 comprises a central core of three pleated antiparallel b-strands and two a-helices. Visual inspection of the two structures (Fig. 2c, d) shows that Lipoprotein-17 domain of Q9PRA0_UREPA has 5 b-strands while the putative lysozyme has only 3 b-strands. The superimposition of the main-chain structures of the Lipoprotein-17 domain and the 2IA7 showed that both structures have a1 helices in their N-terminal regions, and b3, b4, and b5 strands of the Lipoprotein-17 domain overlap well with b-strands of 2IA7, but the putative tail lysozyme lacks the strands b1-b2 and has long a2 helix instead. These do not appear to be similar folds. Hence we conclude that the Lipoprotein 17 domain of QPRA0_UREPA has a novel fold.
The electrostatic surface potential for the Lipoprotein-17 domain of Q9PRA0_UREPA is shown in Fig. 1c . A hydrophobic patch is located in the center of the molecule where the orthogonal b-strands are located. However, the 3D structure does not yet provide any useful clues into the biochemical function of Q9PRA0_UREPA.
The NMR and X-ray structures presented here are the first 3D structures from the large Pfam domain family Lipoprotein-17 (PF04200). Further understanding of the biological activity of Lipoprotein-17 domains will require further studies of the domain, as well as the full-length Q9PRA0-UREPA protein.
